Načítá se...

Imipenem versus moxalactam in the treatment of serious infections.

Imipenem (formerly imipemide, N-formimidoyl thienamycin, or MK0787) was compared to moxalactam in a randomized therapeutic trial involving 39 evaluable patients with serious bacterial infections. Of those treated with imipenem, 89% were cured or improved versus 60% for moxalactam (P = 0.06). Althoug...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Eron, L J, Hixon, D L, Park, C H, Goldenberg, R I, Poretz, D M
Médium: Artigo
Jazyk:Inglês
Vydáno: 1983
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC185393/
https://ncbi.nlm.nih.gov/pubmed/6581755
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!